The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Application of Various Types of Liposomes in Drug Delivery Systems
Open accessAbstract
Liposomes, due to their various forms, require further exploration. These structures can deliver both hydrophilic and hydrophobic drugs for cancer, antibacterial, antifungal, immunomodulation, diagnostics, ophtalmica, vaccines, enzymes and genetic elements. Preparation of liposomes results in different properties for these systems. In addition, based on preparation methods, liposomes types can be unilamellar, multilamellar and giant unilamellar; however, there are many factors and difficulties that affect the development of liposome drug delivery structure. In the present review, we discuss some problems that impact drug delivery by liposomes. In addition, we discuss a new generation of liposomes, which is utilized for decreasing the limitation of the conventional liposomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Yu, N. Y., Wagner, J. R., Laird, M. R., Melli, G., Rey, S., Lo, R., Dao, P., Sahinalp, S. C., Ester, M., Foster, L. J., et al. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq249 · Cited by 2,488
Drug delivery systems: An updated review
Tiwari, G., Tiwari, R., Bannerjee, S., Bhati, L., Pandey, S., Pandey, P., & Sriwastawa, B. (2012) · International Journal of Pharmaceutical Investigation · doi:10.4103/2230-973x.96920 · Cited by 1,671
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Malam, Y., Loizidou, M., & Seifalian, A. M. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.08.004 · Cited by 1,318
A review on phospholipids and their main applications in drug delivery systems
Li, J., Wang, X., Zhang, T., Wang, C., Huang, Z., Luo, X., & Deng, Y. (2015) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2014.09.004 · Cited by 1,003
Novel applications of liposomes
Lasic, D. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01220-7 · Cited by 867
(2001) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)00967-9 · Cited by 814
Bressler, N. M. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(01)01237-5 · Cited by 666
Studies on a high encapsulation of colchicine by a niosome system
Hao, Y., Zhao, F., Li, N., Yang, Y., & Li, K. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00301-0 · Cited by 365
Liposomes as delivery systems for antibiotics
Drulis-Kawa, Z., & Dorotkiewicz-Jach, A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.11.033 · Cited by 356
Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs
Felnerova, D., Viret, J.-F., Glück, R., & Moser, C. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.10.005 · Cited by 296
The use of lipid-based nanocarriers for targeted pain therapies
Hua, S., & Wu, S. Y. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00143 · Cited by 268
Horger, K. S., Estes, D. J., Capone, R., & Mayer, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja805625u · Cited by 225
Targeted Nanomedicines: Effective Treatment Modalities for Cancer, AIDS and Brain Disorders
Muthu, M. S., & Singh, S. (2009) · Nanomedicine · doi:10.2217/17435889.4.1.105 · Cited by 225
Archaeobacterial Ether Lipid Liposomes (Archaeosomes) as Novel Vaccine and Drug Delivery Systems
Patel, G. B., & Sprott, G. D. (1999) · Critical Reviews in Biotechnology · doi:10.1080/0738-859991229170 · Cited by 193
The Vesosome - A Multicompartment Drug Delivery Vehicle
Kisak, E., Coldren, B., Evans, C., Boyer, C., & Zasadzinski, J. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043456197 · Cited by 166
Archaeal tetraether bipolar lipids: Structures, functions and applications
Jacquemet, A., Barbeau, J., Lemiègre, L., & Benvegnu, T. J. (2009) · Biochimie · doi:10.1016/j.biochi.2009.01.006 · Cited by 122
Johnson, E. M., Ojwang, J. O., Székely, A., Wallace, T. L., & Warnock, D. W. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.6.1412 · Cited by 118
Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy
Ichim, C. V. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-8 · Cited by 108
In vitro assessment of archaeosome stability for developing oral delivery systems
Patel, G. B., Agnew, B. J., Deschatelets, L., Fleming, L. P., & Sprott, G. D. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00331-2 · Cited by 104
Preparation and mechanical characterisation of giant unilamellar vesicles by a microfluidic method
Karamdad, K., Law, R. V., Seddon, J. M., Brooks, N. J., & Ces, O. (2014) · Lab on a Chip · doi:10.1039/c4lc01277a · Cited by 104
Vyas, S. P., Subhedar, R., & Jain, S. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.3.0005 · Cited by 102
Pushko, P., Tumpey, T. M., Hoeven, N. V., Belser, J. A., Robinson, R., Nathan, M., Smith, G., Wright, D. C., & Bright, R. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.059 · Cited by 99
Liposomal drug delivery system from laboratory to clinic.
Kshirsagar, N. A., Pandya, S. K., Kirodian, G. B., & Sanath, S. (2005) · PubMed · Cited by 89
Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate
Paliwal, R., Paliwal, S. R., Mishra, N., Mehta, A., & Vyas, S. P. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.06.026 · Cited by 85
Takahashi, M., Kitamoto, D., Asikin, Y., Takara, K., & Wada, K. (2009) · Journal of Oleo Science · doi:10.5650/jos.58.643 · Cited by 71
Bhatia, T., Husen, P., Brewer, J. R., Bagatolli, L. A., Hansen, P. L., Ipsen, J. H., & Mouritsen, O. G. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.09.020 · Cited by 70
Preparation and performance evaluation of emulsomes as a drug delivery system for silybin
Zhou, X., & Chen, Z. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0630-7 · Cited by 57
Formation of Giant Unilamellar Proteo-Liposomes by Osmotic Shock
Motta, I., Gohlke, A., Adrien, V., Li, F., Gardavot, H., Rothman, J. E., & Pincet, F. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b01173 · Cited by 53
Cited by
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
Large, D. E., Abdelmessih, R. G., Fink, E. A., & Auguste, D. T. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113851 · Cited by 877
Németh, Z., Csóka, I., Semnani Jazani, R., Sipos, B., Haspel, H., Kozma, G., Kónya, Z., & Dobó, D. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091798 · Cited by 452
Exosome engineering: Current progress in cargo loading and targeted delivery
Fu, S., Wang, Y., Xia, X., & Zheng, J. C. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100261 · Cited by 444
Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles
Alavi, M., & Hamidi, M. (2019) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2018-0032 · Cited by 405
Self-citationSustainable technologies for liposome preparation
Maja, L., Željko, K., & Mateja, P. (2020) · The Journal of Supercritical Fluids · doi:10.1016/j.supflu.2020.104984 · Cited by 398
Metadata
- Authors
- Alavi, M., Karimi, N., & Safaei, M.
- Venue
- Advanced Pharmaceutical Bulletin
- Publisher
- Maad Rayan Publishing Company
- Published
- 2017-04-13
- Volume
- 7
- Issue
- 1
- Pages
- 3-9
- ISSN
- 2228-5881 (ISSN-L)
- 2251-7308
- OpenAlex
- W2605722715
- Cited by
- 466
- References
- 32
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.